Praxsyn Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PXYN research report →
Price Chart
About the company
Praxsyn Corporation operates as a healthcare enterprise, supplying medical professionals with specific medications and related services for their patients. The company specializes in creating non-narcotic and non-habit-forming treatments, utilizing therapeutic and preventative compounds. These come in various formats, such as transdermal creams, patches, and oral capsules, and are formulated to treat issues like pain management, erectile dysfunction, and metabolic disorders.
- CEO
- Sean Daly
- IPO
- 2010
- Employees
- 66
- HQ
- Las Vegas, NV, US
Get TickerSpark's AI analysis on PXYN
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $6.35K
- P/E
- -0.01
- PEG
- -0.00
- P/S
- 0.08
- P/B
- 0.00
- EV/EBITDA
- -11.85
- Div Yield
- 0.00%
- Gross Margin
- 29.39%
- Op Margin
- -240.85%
- Net Margin
- -695.52%
- ROE
- -20.21%
- ROIC
- -4.71%
Latest fiscal year · YoY change
- Revenue
- $81.38K-90.1%
- Gross Profit
- $23.91K-93.8%
- Op Income
- $-196,000
- Net Income
- $-566,000+83.8%
- EPS
- $-0.00+83.3%
- OCF Growth
- +0.0%
- FCF Growth
- +0.0%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 0.80
- RSI (14)
- 52
- Avg Volume
- 509.76K
No earnings-call transcripts are available for PXYN yet.
- Free Float
- 82.0%
- Shares Outstanding
- 634.67M
- Float Shares
- 520.66M
Our PXYN coverage
Recent articles, reports, and earnings notes.
No research on PXYN yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PXYN report →Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.